Cargando…
Sevelamer arsenite nanoparticle as a Pi-responsive drug carrier and embolic agent for chemoembolization
Arsenic trioxide (As(2)O(3), ATO) has limited therapeutic benefit to treat solid tumors, whether used alone or in combination. Nanoscale drug delivery vehicles have great potential to overcome the limitation of the utility of ATO by rapid renal clearance and dose-limiting toxicity. Polymeric materia...
Autores principales: | Bi, Qiu-Chen, Tang, Jian-Jun, Zhao, Jun, Lv, Yang-Feng, Deng, Zhi-Qiang, Chen, Hong, Xu, Yu-Hua, Xie, Chuan-Sheng, Liang, Qing-Rong, Luo, Rong-Guang, Tang, Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103487/ https://www.ncbi.nlm.nih.gov/pubmed/35532152 http://dx.doi.org/10.1080/10717544.2022.2072541 |
Ejemplares similares
-
Evaluation of the safety and efficacy of transarterial sevelamer embolization in a rabbit liver cancer model: A challenge on the size rule for vascular occlusion
por: Chen, Hong, et al.
Publicado: (2022) -
Intratumoral Pi deprivation benefits chemoembolization therapy via increased accumulation of intracellular doxorubicin
por: Lv, Yang-Feng, et al.
Publicado: (2022) -
Ischemic Colitis in Association with Sevelamer Crystals
por: Keri, K. C., et al.
Publicado: (2019) -
Gastrointestinal complications induced by sevelamer crystals
por: Yuste, Claudia, et al.
Publicado: (2017) -
Sevelamer Carbonate Crystal-Induced Colitis
por: Lai, T., et al.
Publicado: (2020)